ACADIA Pharmaceuticals Inc —— 资产负债表 (NASDAQ:ACAD) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 782.62 M700.12 M587.81 M748.96 M1.19 B1.56 B 负债总额 155.61 M159.23 M187.4 M317.2 M454.96 M336.81 M 权益总额 627.01 M540.89 M400.41 M431.75 M732.79 M1.23 B 负债及股东权益总额 782.62 M700.12 M587.81 M748.96 M1.19 B1.56 B 总债务 —————— 净债务 ——————

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

新闻

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals任命Jonathan M. Poole为董事会成员

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

美国银行因欧盟挫折下调Acadia Pharmaceuticals目标价